Angiotensin II (medication) (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Angiotensin II (medication)" in English language version.

refsWebsite

Global rank English rank

4^th place

2^nd place

447^th place

338^th place

11^th place

8^th place

68^th place

117^th place

102^nd place

76^th place

9,112^th place

7,304^th place

doi.org

Brown SM, Lanspa MJ, Jones JP, Kuttler KG, Li Y, Carlson R, et al. (March 2013). "Survival after shock requiring high-dose vasopressor therapy". Chest. 143 (3): 664–671. doi:10.1378/chest.12-1106. PMC 3590882. PMID 22911566.
Chawla LS, Busse L, Brasha-Mitchell E, Davison D, Honiq J, Alotaibi Z, et al. (October 2014). "Intravenous angiotensin II for the treatment of high-output shock (ATHOS trial): a pilot study". Critical Care. 18 (5): 534. doi:10.1186/s13054-014-0534-9. PMC 4212099. PMID 25286986.
Bradley SE, Parker B (November 1941). "The Hemodynamic Effects of Angiotonin in Normal Man". The Journal of Clinical Investigation. 20 (6): 715–719. doi:10.1172/JCI101265. PMC 435102. PMID 16694877.
Khanna A, English SW, Wang XS, Ham K, Tumlin J, Szerlip H, et al. (August 2017). "Angiotensin II for the Treatment of Vasodilatory Shock". The New England Journal of Medicine. 377 (5): 419–430. doi:10.1056/NEJMoa1704154. hdl:1959.13/1353018. PMID 28528561. S2CID 205102054.
Liaudet L, Calderari B, Pacher P (November 2014). "Pathophysiological mechanisms of catecholamine and cocaine-mediated cardiotoxicity" (PDF). Heart Failure Reviews. 19 (6): 815–824. doi:10.1007/s10741-014-9418-y. PMID 24398587. S2CID 22420796.

"Giapreza EPAR". European Medicines Agency. 23 August 2019. Retrieved 13 June 2024.

Khanna A, English SW, Wang XS, Ham K, Tumlin J, Szerlip H, et al. (August 2017). "Angiotensin II for the Treatment of Vasodilatory Shock". The New England Journal of Medicine. 377 (5): 419–430. doi:10.1056/NEJMoa1704154. hdl:1959.13/1353018. PMID 28528561. S2CID 205102054.

Kaufman MB (March 2018). "Pharmaceutical Approval Update". P & T. 43 (3): 141–170. PMC 5821238. PMID 29491694.
Brown SM, Lanspa MJ, Jones JP, Kuttler KG, Li Y, Carlson R, et al. (March 2013). "Survival after shock requiring high-dose vasopressor therapy". Chest. 143 (3): 664–671. doi:10.1378/chest.12-1106. PMC 3590882. PMID 22911566.
Chawla LS, Busse L, Brasha-Mitchell E, Davison D, Honiq J, Alotaibi Z, et al. (October 2014). "Intravenous angiotensin II for the treatment of high-output shock (ATHOS trial): a pilot study". Critical Care. 18 (5): 534. doi:10.1186/s13054-014-0534-9. PMC 4212099. PMID 25286986.
Bradley SE, Parker B (November 1941). "The Hemodynamic Effects of Angiotonin in Normal Man". The Journal of Clinical Investigation. 20 (6): 715–719. doi:10.1172/JCI101265. PMC 435102. PMID 16694877.
Khanna A, English SW, Wang XS, Ham K, Tumlin J, Szerlip H, et al. (August 2017). "Angiotensin II for the Treatment of Vasodilatory Shock". The New England Journal of Medicine. 377 (5): 419–430. doi:10.1056/NEJMoa1704154. hdl:1959.13/1353018. PMID 28528561. S2CID 205102054.
Liaudet L, Calderari B, Pacher P (November 2014). "Pathophysiological mechanisms of catecholamine and cocaine-mediated cardiotoxicity" (PDF). Heart Failure Reviews. 19 (6): 815–824. doi:10.1007/s10741-014-9418-y. PMID 24398587. S2CID 22420796.

Kaufman MB (March 2018). "Pharmaceutical Approval Update". P & T. 43 (3): 141–170. PMC 5821238. PMID 29491694.
Brown SM, Lanspa MJ, Jones JP, Kuttler KG, Li Y, Carlson R, et al. (March 2013). "Survival after shock requiring high-dose vasopressor therapy". Chest. 143 (3): 664–671. doi:10.1378/chest.12-1106. PMC 3590882. PMID 22911566.
Chawla LS, Busse L, Brasha-Mitchell E, Davison D, Honiq J, Alotaibi Z, et al. (October 2014). "Intravenous angiotensin II for the treatment of high-output shock (ATHOS trial): a pilot study". Critical Care. 18 (5): 534. doi:10.1186/s13054-014-0534-9. PMC 4212099. PMID 25286986.
Bradley SE, Parker B (November 1941). "The Hemodynamic Effects of Angiotonin in Normal Man". The Journal of Clinical Investigation. 20 (6): 715–719. doi:10.1172/JCI101265. PMC 435102. PMID 16694877.

"Giapreza- angiotensin ii injection". DailyMed. 20 June 2020. Retrieved 17 September 2020.

Khanna A, English SW, Wang XS, Ham K, Tumlin J, Szerlip H, et al. (August 2017). "Angiotensin II for the Treatment of Vasodilatory Shock". The New England Journal of Medicine. 377 (5): 419–430. doi:10.1056/NEJMoa1704154. hdl:1959.13/1353018. PMID 28528561. S2CID 205102054.
Liaudet L, Calderari B, Pacher P (November 2014). "Pathophysiological mechanisms of catecholamine and cocaine-mediated cardiotoxicity" (PDF). Heart Failure Reviews. 19 (6): 815–824. doi:10.1007/s10741-014-9418-y. PMID 24398587. S2CID 22420796.